We are live on ! Find out more
WFM

Wilmington Funds Management Portfolio holdings

AUM $988M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+4.48%
1 Year Est. Return
+26.05%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$988M
AUM Growth
+$67.7M
Cap. Flow
+$35.7M
Cap. Flow %
3.61%
Top 10 Hldgs %
10.81%
Holding
873
New
103
Increased
253
Reduced
220
Closed
127

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$6.38M
2
AGN
Allergan Inc
AGN
+$5.74M
3
OII icon
Oceaneering
OII
+$4.45M
4
FRX
FOREST LABORATORIES INC
FRX
+$3.94M
5
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
+$3.61M

Top Sells

Rank Stock Value
1
CTXS
Citrix Systems Inc
CTXS
+$5.03M
2
XOM icon
ExxonMobil
XOM
+$4.42M
3
GE icon
GE Aerospace
GE
+$3.28M
4
CVX icon
Chevron
CVX
+$2.84M
5
HLF icon
Herbalife
HLF
+$2.82M

Sector Composition

Rank Sector Weight
1 Industrials 15.33%
2 Consumer Discretionary 12.29%
3 Healthcare 11.76%
4 Technology 11.66%
5 Real Estate 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTN icon
551
Vail Resorts
MTN
$5.7B
$283K 0.03%
3,670
– –
IDTI
552
DELISTED
Integrated Device Technology I
IDTI
$283K 0.03%
+18,290
New +$235K
ATVI
553
DELISTED
Activision Blizzard
ATVI
$283K 0.03%
+12,670
New +$260K
FIZZ icon
554
National Beverage
FIZZ
$3.06B
$282K 0.03%
29,856
– –
FLR icon
555
Fluor
FLR
$6.54B
$282K 0.03%
3,670
+200
+6% +$15.2K
ELV icon
556
Elevance Health
ELV
$81.5B
$281K 0.03%
2,610
-2,900
-53% -$299K
IART icon
557
Integra LifeSciences
IART
$1.28B
$281K 0.03%
+14,623
New +$272K
CHRW icon
558
C.H. Robinson
CHRW
$20.5B
$280K 0.03%
4,384
– –
O icon
559
Realty Income
O
$61.1B
$280K 0.03%
6,512
-2,580
-28% -$108K
LFCR icon
560
Lifecore Biomedical
LFCR
$162M
$279K 0.03%
22,370
– –
SIG icon
561
Signet Jewelers
SIG
$3.84B
$279K 0.03%
+2,520
New +$262K
KS
562
DELISTED
KapStone Paper and Pack Corp.
KS
$279K 0.03%
8,420
– –
COHR
563
DELISTED
Coherent Inc
COHR
$278K 0.03%
+4,204
New +$260K
TFC icon
564
Truist Financial
TFC
$63.9B
$276K 0.03%
6,990
-22,546
-76% -$864K
FANG icon
565
Diamondback Energy
FANG
$56B
$275K 0.03%
+3,100
New +$236K
HY icon
566
Hyster-Yale Materials Handling
HY
$576M
$275K 0.03%
+3,106
New +$282K
MWA icon
567
Mueller Water Products
MWA
$3.94B
$275K 0.03%
31,879
– –
POOL icon
568
Pool Corp
POOL
$7.05B
$275K 0.03%
4,855
– –
ULTA icon
569
Ulta Beauty
ULTA
$21.8B
$274K 0.03%
+3,000
New +$270K
WAB icon
570
Wabtec
WAB
$49.3B
$274K 0.03%
+3,320
New +$256K
SLAB icon
571
Silicon Laboratories
SLAB
$7.14B
$273K 0.03%
+5,550
New +$264K
WAT icon
572
Waters Corp
WAT
$37.3B
$273K 0.03%
+2,610
New +$275K
CASY icon
573
Casey's General Stores
CASY
$32.1B
$270K 0.03%
3,836
– –
ES icon
574
Eversource Energy
ES
$28.1B
$270K 0.03%
5,713
– –
VRNT
575
DELISTED
Verint Systems
VRNT
$270K 0.03%
10,810
– –
21 22
23
24 25

Similar funds

SCM
Stux Capital Management New York $766M AUM 28.03% 1-Year Est. Return
MIU
Man Investments (UK) London, United Kingdom $1.29B AUM 31.85% 1-Year Est. Return
SR
Swiss Reinsurance Zurich, Switzerland $664M AUM 11.24% 1-Year Est. Return
CH
Cavalane Holdings Sydney, Australia $558M AUM
WTIM
Wilmington Trust Investment Management Wilmington, Delaware $492M AUM 25.19% 1-Year Est. Return
FOAM
Five Oceans Asset Management Sydney, Australia $438M AUM 24.83% 1-Year Est. Return
BII
Baring International Investment London, United Kingdom $1.57B AUM 24.97% 1-Year Est. Return
HGI
Hansberger Global Investors Ft Lauderdale, Florida $354M AUM 17.2% 1-Year Est. Return

Wilmington Funds Management's Q2 2014 Portfolio in Review

As of Q2 2014, Wilmington Funds Management held 873 positions worth $988M, up 7.4% from $920M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Wilmington Funds Management deployed $35.7M of net new capital in Q2 2014, opening 103 new positions and adding to 253 existing holdings. Its largest new stake was AstraZeneca: 88,300 shares worth $6.56M.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Citrix Systems Inc, an estimated $5.03M trimmed.

  • Wilmington Funds Management's largest Q2 2014 buy was AstraZeneca: 88,300 shares worth $6.56M.
  • Wilmington Funds Management added most to Allergan Inc in Q2 2014, an estimated $5.74M increase.
  • Wilmington Funds Management's biggest Q2 2014 reduction was Citrix Systems Inc, cutting an estimated $5.03M.
  • Wilmington Funds Management fully exited Wolfspeed in Q2 2014, selling an estimated $1.9M.
  • Wilmington Funds Management's ten largest holdings make up 11% of its $988M portfolio in Q2 2014.
  • Wilmington Funds Management opened 103 new positions and closed 127 in Q2 2014.
  • Wilmington Funds Management's portfolio value rose 7.4% quarter-over-quarter to $988M.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.